Reply to the letter to the editor: The risk of latent tuberculosis infection in patients with type 2 diabetes mellitus according to use of sodium-glucose cotransporter 2 inhibitors: A national database cohort study | Synapse
April 13, 2026Open Access
Reply to the letter to the editor: The risk of latent tuberculosis infection in patients with type 2 diabetes mellitus according to use of sodium-glucose cotransporter 2 inhibitors: A national database cohort study
Key Points
This study aims to investigate the relationship between SGLT2 inhibitors and the risk of latent tuberculosis infection in patients with type 2 diabetes.
Analysis of a national database cohort.
Comparison of patients using SGLT2 inhibitors versus those who do not.
Assessment of latent tuberculosis infection rates.
Identified increased infection risk among users of SGLT2 inhibitors.
Statistical analysis showed significant correlations between medication use and infection rates.
Abstract
We sincerely appreciate the insightful comments from the experts regarding our study on SGLT2 inhibitors and latent tuberculosis infection